These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32713720)

  • 21. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
    McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meaningful measures in cancer cachexia: implications for practice and research.
    McDonald JJ; Fallon MT; Laird BJA
    Curr Opin Support Palliat Care; 2019 Dec; 13(4):323-327. PubMed ID: 31599817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients.
    Vigano AAL; Morais JA; Ciutto L; Rosenthall L; di Tomasso J; Khan S; Olders H; Borod M; Kilgour RD
    Clin Nutr; 2017 Oct; 36(5):1378-1390. PubMed ID: 27793524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endpoints in clinical trials in cancer cachexia: where to start?
    Laird BJA; Balstad TR; Solheim TS
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):445-452. PubMed ID: 30299325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Activin A and myostatin in human cancer cachexia.
    Loumaye A; de Barsy M; Nachit M; Lause P; Frateur L; van Maanen A; Trefois P; Gruson D; Thissen JP
    J Clin Endocrinol Metab; 2015 May; 100(5):2030-8. PubMed ID: 25751105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia.
    Herodes M; Anderson LJ; Shober S; Schur EA; Graf SA; Ammer N; Salas R; Marcelli M; Garcia JM
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):835-846. PubMed ID: 36860137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function.
    Stephens NA; Gray C; MacDonald AJ; Tan BH; Gallagher IJ; Skipworth RJ; Ross JA; Fearon KC; Greig CA
    Clin Nutr; 2012 Aug; 31(4):499-505. PubMed ID: 22296872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of different muscle mass measurements on the diagnosis of cancer cachexia.
    Blauwhoff-Buskermolen S; Langius JAE; Becker A; Verheul HMW; de van der Schueren MAE
    J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):615-622. PubMed ID: 28447434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body composition, physical function and quality of life in healthy men and across different stages of prostate cancer.
    Hanson ED; Stopforth CK; Alzer M; Carver J; Lucas AR; Whang YE; Milowsky MI; Bartlett DB; Harrison MR; Hayes A; Bitting RL; Deal AM; Hackney AC; Battaglini CL
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):725-732. PubMed ID: 33495569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Relationship between Exercise Capacity and Muscle Strength, Physical Activity, Fatigue and Quality of Life in Patients with Cancer Cachexia.
    Polat K; Karadibak D; Güç ZGS; Yavuzşen T; Öztop İ
    Nutr Cancer; 2024; 76(1):55-62. PubMed ID: 37917566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of Life and Symptom Burden Improve in Patients Attending a Multidisciplinary Clinical Service for Cancer Cachexia: A Retrospective Observational Review.
    Bland KA; Harrison M; Zopf EM; Sousa MS; Currow DC; Ely M; Agar M; Butcher BE; Vaughan V; Dowd A; Martin P
    J Pain Symptom Manage; 2021 Sep; 62(3):e164-e176. PubMed ID: 33652095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Protein Intake on Lean Body Mass in Functionally Limited Older Men: A Randomized Clinical Trial.
    Bhasin S; Apovian CM; Travison TG; Pencina K; Moore LL; Huang G; Campbell WW; Li Z; Howland AS; Chen R; Knapp PE; Singer MR; Shah M; Secinaro K; Eder RV; Hally K; Schram H; Bearup R; Beleva YM; McCarthy AC; Woodbury E; McKinnon J; Fleck G; Storer TW; Basaria S
    JAMA Intern Med; 2018 Apr; 178(4):530-541. PubMed ID: 29532075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrinopathies and cancer cachexia.
    Dev R; Del Fabbro E; Dalal S
    Curr Opin Support Palliat Care; 2019 Dec; 13(4):286-291. PubMed ID: 31567482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance Training Impact on Mobility, Muscle Strength and Lean Mass in Pancreatic Cancer Cachexia: A Randomized Controlled Trial.
    Kamel FH; Basha MA; Alsharidah AS; Salama AB
    Clin Rehabil; 2020 Nov; 34(11):1391-1399. PubMed ID: 32660264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.
    Tessier AJ; Wing SS; Rahme E; Morais JA; Chevalier S
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):985-999. PubMed ID: 31307126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
    Emami A; Saitoh M; Valentova M; Sandek A; Evertz R; Ebner N; Loncar G; Springer J; Doehner W; Lainscak M; Hasenfuß G; Anker SD; von Haehling S
    Eur J Heart Fail; 2018 Nov; 20(11):1580-1587. PubMed ID: 30160804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Stair Climb Power Test as an Efficacy Outcome in Randomized Trials of Function Promoting Therapies in Older Men.
    Gagliano-Jucá T; Li Z; Pencina KM; Traustadóttir T; Travison TG; Woodhouse L; Basaria S; Tsitouras PD; Harman SM; Bhasin S; Storer TW
    J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1167-1175. PubMed ID: 31282538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression.
    Lopez P; Taaffe DR; Newton RU; Galvão DA
    Med Sci Sports Exerc; 2021 Mar; 53(3):459-469. PubMed ID: 32890199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.